PL4106757T3 - Sposoby z udziałem inhibitora elastazy neutrofilowej, alwelestatu, do leczenia choroby układu oddechowego, w której pośredniczy niedobór alfa-1 antytrypsyny - Google Patents
Sposoby z udziałem inhibitora elastazy neutrofilowej, alwelestatu, do leczenia choroby układu oddechowego, w której pośredniczy niedobór alfa-1 antytrypsynyInfo
- Publication number
- PL4106757T3 PL4106757T3 PL21714345.2T PL21714345T PL4106757T3 PL 4106757 T3 PL4106757 T3 PL 4106757T3 PL 21714345 T PL21714345 T PL 21714345T PL 4106757 T3 PL4106757 T3 PL 4106757T3
- Authority
- PL
- Poland
- Prior art keywords
- alvelestat
- alpha
- respiratory disease
- methods involving
- neutrophil elastase
- Prior art date
Links
- QNQZWEGMKJBHEM-UHFFFAOYSA-N 6-methyl-5-(2-methylpyrazol-3-yl)-n-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound O=C1N(C=2C=C(C=CC=2)C(F)(F)F)C(C)=C(C=2N(N=CC=2)C)C=C1C(=O)NCC1=CC=C(S(C)(=O)=O)C=N1 QNQZWEGMKJBHEM-UHFFFAOYSA-N 0.000 title 1
- 102000002255 Secretory Proteinase Inhibitory Proteins Human genes 0.000 title 1
- 108010000303 Secretory Proteinase Inhibitory Proteins Proteins 0.000 title 1
- 208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 title 1
- 229950005666 alvelestat Drugs 0.000 title 1
- 239000003591 leukocyte elastase inhibitor Substances 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2005519.0A GB202005519D0 (en) | 2020-04-16 | 2020-04-16 | Elastase inhibition |
GBGB2005520.8A GB202005520D0 (en) | 2020-04-16 | 2020-04-16 | Elastase inhibition |
US202062706195P | 2020-08-04 | 2020-08-04 | |
PCT/GB2021/050653 WO2021209739A1 (en) | 2020-04-16 | 2021-03-16 | Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency |
Publications (1)
Publication Number | Publication Date |
---|---|
PL4106757T3 true PL4106757T3 (pl) | 2024-01-22 |
Family
ID=78083570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL21714345.2T PL4106757T3 (pl) | 2020-04-16 | 2021-03-16 | Sposoby z udziałem inhibitora elastazy neutrofilowej, alwelestatu, do leczenia choroby układu oddechowego, w której pośredniczy niedobór alfa-1 antytrypsyny |
Country Status (16)
Country | Link |
---|---|
US (2) | US20230218596A1 (de) |
EP (2) | EP4252850A3 (de) |
JP (1) | JP2023522010A (de) |
AU (1) | AU2021256835A1 (de) |
DK (1) | DK4106757T3 (de) |
ES (1) | ES2962498T3 (de) |
FI (1) | FI4106757T3 (de) |
HR (1) | HRP20231065T1 (de) |
HU (1) | HUE064089T2 (de) |
IL (1) | IL297211A (de) |
LT (1) | LT4106757T (de) |
MX (1) | MX2022012942A (de) |
PL (1) | PL4106757T3 (de) |
PT (1) | PT4106757T (de) |
SI (1) | SI4106757T1 (de) |
WO (2) | WO2021209739A1 (de) |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674708A (en) | 1989-06-23 | 1997-10-07 | Trustees Of The University Of Pennsylvania | α-1-antichymotrypsin analogues having elastase inhibitory activity |
DE573603T1 (de) | 1991-03-01 | 1999-05-06 | Dyax Corp | Hemmstoffe für menschliche neutrophile elastase und menschliches kathepsin g. |
DE69229552T2 (de) | 1991-05-23 | 1999-12-23 | Merrell Pharma Inc | Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau |
US5216022A (en) | 1991-12-19 | 1993-06-01 | Cortech, Inc. | Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase |
AU4077193A (en) | 1992-04-16 | 1993-11-18 | Zeneca Limited | Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
US5486529A (en) | 1992-04-16 | 1996-01-23 | Zeneca Limited | Certain pyridyl ketones for treating diseases involving leukocyte elastase |
AU3959693A (en) | 1992-04-16 | 1993-11-18 | Zeneca Limited | Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
US5441960A (en) | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
GB9307555D0 (en) | 1992-04-16 | 1993-06-02 | Zeneca Ltd | Heterocyclic compounds |
GB9211783D0 (en) | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
GB9214053D0 (en) | 1992-07-02 | 1992-08-12 | Ici Plc | Heterocyclic amides |
GB9402680D0 (en) | 1994-02-11 | 1994-04-06 | Zeneca Ltd | Pyrrolidine derivatives |
KR100366328B1 (ko) | 1994-06-02 | 2003-03-06 | 메렐 파마슈티칼스 인크. | 엘라스타제의퍼플루오로알킬케톤억제제및이들의제조방법 |
JP3623799B2 (ja) | 1994-06-02 | 2005-02-23 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 新しいエラスターゼ阻害剤 |
US5618792A (en) | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
GB9502152D0 (en) | 1995-02-03 | 1995-03-29 | Zeneca Ltd | Proline derivatives |
US5994344A (en) | 1996-03-28 | 1999-11-30 | Glaxo Wellcome Inc. | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
ATE297466T1 (de) | 1996-04-12 | 2005-06-15 | American Nat Red Cross | Mutierter plasminogen-aktivator-inhibitor typ 1 und seine verwendungen |
GB9719187D0 (en) | 1997-09-09 | 1997-11-12 | Glaxo Group Ltd | Compounds |
PE107899A1 (es) | 1997-09-09 | 1999-11-17 | Glaxo Group Ltd | Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria |
EP1089752A4 (de) | 1998-06-03 | 2002-01-02 | Cortech Inc | Alpha-keto oxadiazole als serinprotease inhibitoren |
JP2004517028A (ja) | 1998-06-03 | 2004-06-10 | コーテック インコーポレーテッド | セリンプロテアーゼ阻害剤としてのα−ケトオキサジアゾール類含有インドールおよびテトラヒドロイソキノリン |
US20030069187A1 (en) | 2001-10-05 | 2003-04-10 | Rao Srinivasa K. | Elastase inhibitors |
US20030119073A1 (en) | 2001-12-21 | 2003-06-26 | Stephen Quirk | Sensors and methods of detection for proteinase enzymes |
GB0219896D0 (en) | 2002-08-27 | 2002-10-02 | Bayer Ag | Dihydropyridine derivatives |
TW200500341A (en) | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
SE0302323D0 (sv) | 2003-08-28 | 2003-08-28 | Astrazeneca Ab | Novel compounds |
SE0302324D0 (sv) | 2003-08-28 | 2003-08-28 | Astrazeneca Ab | Novel compounds |
SE0302486D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
SE0302487D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
US7893073B2 (en) | 2004-02-26 | 2011-02-22 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclic derivatives |
WO2005082864A1 (en) | 2004-02-26 | 2005-09-09 | Bayer Healthcare Ag | 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors |
WO2006070012A1 (en) | 2004-12-30 | 2006-07-06 | Ingenium Pharmaceuticals Ag | Agents useful in treating inflammatory bowel disease |
GB0502258D0 (en) | 2005-02-03 | 2005-03-09 | Argenta Discovery Ltd | Compounds and their use |
TW200700392A (en) | 2005-03-16 | 2007-01-01 | Astrazeneca Ab | Novel compounds |
GB0512940D0 (en) | 2005-06-24 | 2005-08-03 | Argenta Discovery Ltd | Compounds and their use |
GB0605469D0 (en) | 2006-03-17 | 2006-04-26 | Argenta Discovery Ltd | Multimers of heterocyclic compounds and their use |
BRPI0711169A2 (pt) | 2006-05-04 | 2011-08-23 | Argenta Discovery Ltd | tetrahidropirrolopiridinadionas e seu uso como inibidores de elastase neutrófilo humano |
WO2009013444A1 (en) | 2007-07-25 | 2009-01-29 | Argenta Discovery Limited | Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
TW200808771A (en) | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds II |
TW200808763A (en) | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds I |
WO2007140117A1 (en) | 2006-05-23 | 2007-12-06 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
WO2007137080A2 (en) | 2006-05-23 | 2007-11-29 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
ES2293832B1 (es) | 2006-07-17 | 2009-05-04 | Cargoflet S.A. | Sistema de transporte masivo de gas natural a alta presion por via maritima. |
US20110003858A1 (en) | 2006-09-04 | 2011-01-06 | Bergstroem Lena | Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors |
DK2066662T3 (da) | 2006-09-21 | 2013-01-07 | Kyorin Seiyaku Kk | Serinhydrolaseinhibitorer |
DK2104535T3 (da) | 2007-01-10 | 2011-04-04 | Irm Llc | Forbindelser og sammensætninger som kanalaktiverende proteaseinhibitorer |
JP2010518099A (ja) | 2007-02-09 | 2010-05-27 | アイアールエム・リミテッド・ライアビリティ・カンパニー | チャネル活性化プロテアーゼ阻害剤としての化合物および組成物 |
WO2008104752A1 (en) | 2007-02-26 | 2008-09-04 | Astrazeneca Ab | Dihydropyridones as elastase inhibitors |
WO2009037413A1 (en) | 2007-09-19 | 2009-03-26 | Argenta Discovery Limited | Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases |
WO2009058076A1 (en) | 2007-11-02 | 2009-05-07 | Astrazeneca Ab | 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
WO2009061271A1 (en) | 2007-11-06 | 2009-05-14 | Astrazeneca Ab | Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
WO2009060206A1 (en) | 2007-11-07 | 2009-05-14 | Argenta Discovery Limited | 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use |
WO2009060158A1 (en) | 2007-11-07 | 2009-05-14 | Argenta Discovery Limited | 4- (4-cyanophenyl) -1- (3-trifluoromethylphenyl) -3,4, 6, 7-tetrahydro-1h-pyrrolo [3, 4- d] pyrimidine-2, 5-dione derivatives and their use as human neutrophil elastase inhibitors |
GB0817429D0 (en) | 2008-09-23 | 2008-10-29 | Argenta Discovery Ltd | Enzyme inhibitors |
TW201036957A (en) * | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
CA2773618A1 (en) | 2009-10-02 | 2011-04-07 | Astrazeneca Ab | 2-pyridone compounds used as inhibitors of neutrophil elastase |
US20110212181A1 (en) | 2010-02-26 | 2011-09-01 | The University Of Hong Kong | Compositions and methods for treating chronic respiratory inflammation |
US20110224229A1 (en) | 2010-03-10 | 2011-09-15 | Astrazeneca Ab | Novel Crystalline Form |
GB201004179D0 (en) | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
GB201004178D0 (en) | 2010-03-12 | 2010-04-28 | Pulmagen Therapeutics Inflamma | Enzyme inhibitors |
RU2622643C2 (ru) | 2011-09-14 | 2017-06-19 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные тетрагидротриазолопиримидина в качестве ингибиторов нейтрофильной эластазы человека |
WO2013084199A1 (en) | 2011-12-07 | 2013-06-13 | Universidade De Lisboa | Boron heterocycles as new inhibitors of human neutrophil elastase |
IN2015DN00202A (de) | 2012-07-12 | 2015-06-12 | Chiesi Farma Spa | |
US9102624B2 (en) | 2012-08-23 | 2015-08-11 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
US20140057920A1 (en) | 2012-08-23 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
US20140057926A1 (en) | 2012-08-23 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
US20140221335A1 (en) | 2013-02-06 | 2014-08-07 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9115093B2 (en) | 2013-03-04 | 2015-08-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
CN105873933A (zh) | 2013-12-16 | 2016-08-17 | 奇斯药制品公司 | 作为人中性白细胞弹性蛋白酶抑制剂的四氢三唑并嘧啶衍生物 |
MX2016008468A (es) | 2013-12-27 | 2016-09-26 | Polyphor Ag | Peptidomimeticos de horquilla beta como inhibidores de elastasa selectivos. |
HUE059846T2 (hu) | 2013-12-27 | 2023-01-28 | Spexis Ag | Béta-hajtû peptidomimimetikumok, mint szelektív elasztáz inhibitorok |
US9221807B2 (en) | 2014-02-21 | 2015-12-29 | Boehringer Ingelheim International Gmbh | Substituted pyridones and pyrazinones and their use as inhibitors of neutrophil elastase activity |
WO2015200349A2 (en) * | 2014-06-24 | 2015-12-30 | The California Institute For Biomedical Research | Elastase inhibitors |
US9290457B2 (en) | 2014-07-31 | 2016-03-22 | Boehringer Ingelheim International Gmbh | Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9657015B2 (en) * | 2014-07-31 | 2017-05-23 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9475779B2 (en) | 2014-07-31 | 2016-10-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9440930B2 (en) | 2014-07-31 | 2016-09-13 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9458113B2 (en) | 2014-07-31 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
EP3193910A1 (de) | 2014-08-05 | 2017-07-26 | Réunion Therapeutics B.V. | Mutante von blutegelabgeleiteten inhibitoren der neutrophilen elastase und verwendungen davon |
WO2016050835A2 (en) | 2014-10-02 | 2016-04-07 | Ruprecht-Karls-Universität Heidelberg | Selective inhibitors of neutrophil elastase for treating neuropathic pain and chronic pain states harbouring a neuropathic component |
AR106958A1 (es) | 2015-12-14 | 2018-03-07 | Chiesi Farm Spa | Derivados de tetrahidrotriazolopirimidina útiles como inhibidores de hne |
CN109311850B (zh) | 2016-05-31 | 2021-11-19 | 奇斯药制品公司 | 作为人嗜中性粒细胞弹性蛋白酶抑制剂的咪唑酮化合物 |
JP2023500182A (ja) * | 2019-09-17 | 2023-01-05 | メレオ バイオファーマ 4 リミテッド | 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット |
WO2021178448A1 (en) * | 2020-03-02 | 2021-09-10 | Motor Life Sciences, Llc | Compositions and methods for diagnosing, preventing, and treating amyotrophic lateral sclerosis in patients with hypofunctional anti-trypsin activity |
-
2021
- 2021-03-16 FI FIEP21714345.2T patent/FI4106757T3/fi active
- 2021-03-16 PT PT217143452T patent/PT4106757T/pt unknown
- 2021-03-16 ES ES21714345T patent/ES2962498T3/es active Active
- 2021-03-16 HR HRP20231065TT patent/HRP20231065T1/hr unknown
- 2021-03-16 JP JP2022562608A patent/JP2023522010A/ja active Pending
- 2021-03-16 WO PCT/GB2021/050653 patent/WO2021209739A1/en unknown
- 2021-03-16 HU HUE21714345A patent/HUE064089T2/hu unknown
- 2021-03-16 US US17/995,908 patent/US20230218596A1/en active Pending
- 2021-03-16 MX MX2022012942A patent/MX2022012942A/es unknown
- 2021-03-16 LT LTEPPCT/GB2021/050653T patent/LT4106757T/lt unknown
- 2021-03-16 WO PCT/GB2021/050658 patent/WO2021209740A1/en active Application Filing
- 2021-03-16 US US17/995,909 patent/US20230190723A1/en active Pending
- 2021-03-16 DK DK21714345.2T patent/DK4106757T3/da active
- 2021-03-16 SI SI202130071T patent/SI4106757T1/sl unknown
- 2021-03-16 IL IL297211A patent/IL297211A/en unknown
- 2021-03-16 EP EP23187058.5A patent/EP4252850A3/de active Pending
- 2021-03-16 EP EP21714345.2A patent/EP4106757B1/de active Active
- 2021-03-16 AU AU2021256835A patent/AU2021256835A1/en active Pending
- 2021-03-16 PL PL21714345.2T patent/PL4106757T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
US20230190723A1 (en) | 2023-06-22 |
EP4106757B1 (de) | 2023-08-23 |
HRP20231065T1 (hr) | 2023-12-22 |
LT4106757T (lt) | 2023-11-10 |
JP2023522010A (ja) | 2023-05-26 |
SI4106757T1 (sl) | 2023-11-30 |
US20230218596A1 (en) | 2023-07-13 |
WO2021209739A1 (en) | 2021-10-21 |
ES2962498T3 (es) | 2024-03-19 |
DK4106757T3 (da) | 2023-10-23 |
EP4106757A1 (de) | 2022-12-28 |
IL297211A (en) | 2022-12-01 |
PT4106757T (pt) | 2023-11-17 |
EP4252850A3 (de) | 2023-11-15 |
FI4106757T3 (fi) | 2023-10-23 |
EP4252850A2 (de) | 2023-10-04 |
HUE064089T2 (hu) | 2024-02-28 |
MX2022012942A (es) | 2023-01-11 |
WO2021209740A1 (en) | 2021-10-21 |
AU2021256835A1 (en) | 2022-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012145624A3 (en) | Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies | |
HK1127599A1 (en) | 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial | |
DK2024367T3 (da) | Tetrahydropyrrolopyrimidindioner og deres anvendelse som inhibitorer af human neutrofil elastase | |
EP3980540A4 (de) | Verfahren zur behandlung von alpha-1-antitrypsin-mangel (aatd) | |
WO2008103277A3 (en) | Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors | |
DK2183268T3 (da) | Fremgangsmåder til rensning af alpha-1-antitrypsin og apolipoprotein A-1 | |
WO2008143633A3 (en) | Compounds and methods for treatment of alpha-1 antitrypsin deficiency | |
WO2017001936A3 (en) | Therapeutic inhibitory compounds | |
WO2008016883A3 (en) | Inhibitors of plasma kallikrein | |
WO2009045356A8 (en) | Microrna compositions in the treatment of vegf-mediated disorders | |
ZA201100026B (en) | 4-(pyridin-4-yl)-1h-(1,3,5)triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases | |
IL281063A (en) | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack | |
CY1117379T1 (el) | Παραγωγα ιμιδαζολιου ως αναστολεις toy tafi-a | |
DE602006014630D1 (de) | Automatische Maschine zum Verarbeiten von Artikeln in der Tabakindustrie sowie entsprechendes Kontrollverfahren | |
EP4106815A4 (de) | Verfahren zur behandlung von asthma oder allergien | |
PL4106757T3 (pl) | Sposoby z udziałem inhibitora elastazy neutrofilowej, alwelestatu, do leczenia choroby układu oddechowego, w której pośredniczy niedobór alfa-1 antytrypsyny | |
TW200716777A (en) | Real-time monitoring and controlling sputter target erosion | |
MX2022002054A (es) | Uso de un inhibidor de la elastasa de neutrofilo en la enfermedad pulmonar. | |
MY148565A (en) | Agent for therapy and/or improvement of disseminated intravascular coagulation | |
GB2592759B (en) | New manufacturing process for 2-phase spray conditioner | |
EP3940384A4 (de) | Verfahren zum screening einer verbindung zur behandlung oder vorbeugung von polyq-bedingten neurodegenerativen erkrankungen | |
IL304221A (en) | A method for treating chronic kidney diseases | |
GB202005519D0 (en) | Elastase inhibition | |
GB202005520D0 (en) | Elastase inhibition | |
ZA202208441B (en) | Manufacturing method for high-strength cold-rolled pipe |